Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2010
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305143 Pyrrolopyrimidine compounds
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305113 Substituted Imidazopyridazines as Lipid Kinase Inhibitors
12/02/2010US20100305108 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
12/02/2010US20100305102 Heterocycle-substituted piperazino-dihydrothienopyrimidines
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305088 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
12/02/2010US20100305086 Pharmaceutical Compositions for the Treatment of Pain
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305077 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
12/02/2010US20100305074 Niacin-based pharmaceutical compositions
12/02/2010US20100305054 Concentrated aqueous azalide formulations
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100303935 Medicinal Composition
12/02/2010US20100303923 Endotoxin adsorbent for the prevention and treatment of autoimmune diseases
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303908 Pharmaceutical composition comprising desloratadine
12/02/2010US20100303907 Standardized plant extract, process for obtaining the same and uses thereof
12/02/2010US20100303883 Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems
12/02/2010US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303813 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
12/02/2010US20100303810 Method for treating lupus
12/02/2010US20100303789 Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases
12/02/2010US20100303788 Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
12/02/2010US20100303777 Delivery of binding molecules to induce immunomodulation
12/02/2010US20100303758 Novel Glucocorticoid Receptor Agonists
12/02/2010US20100303757 Methods of Treating Chronic Neurogenic Inflammation Using Interleukin Retargeted Endopepidases
12/02/2010US20100303741 Wolfberries and inflammation
12/02/2010US20100303721 Use of Parasitic Biological Agents for Diseases Prevention and Control
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010US20100300438 Method and sedation delivery system including a pump assembly and a co-formulation of first and second drugs
12/02/2010DE102009022794A1 Verwendung von Hemmstoffen der HAT und TMPRSS2 als Arzneimittel Use of inhibitors of HAT and TMPRSS2 as drugs
12/02/2010CA2763327A1 Inhibition 0f inflammation using antagonists of muc1
12/02/2010CA2763207A1 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010CA2761597A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256116A2 Aryl sulfonamides
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255820A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/01/2010EP2255806A2 Fentanyl composition for nasal administration
12/01/2010EP2255803A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2254870A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP2254869A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP2254867A1 Substituted sulfonamide derivatives
12/01/2010EP2254864A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
12/01/2010EP2254597A2 Methods of treatment using anti-mif antibodies
12/01/2010EP2254579A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN201658672U Improved dogskin plaster
12/01/2010CN1935192B Chinese medicine composition, and its preparing method and quality control method
12/01/2010CN1857237B New use of falcarindiol
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903378A Aminotriazole derivatives
12/01/2010CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903359A Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903358A Perhydrochinoxalin-derivate
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903035A Methods of treating chronic neurogenic inflammation using modified clostridial toxins
12/01/2010CN101899444A Full-length polynucleotide sequence for coding chicken II-type collagen and application thereof
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899108A Novel polypeptide based on human TLR9 receptor functional domain segment LRR11 and applications thereof
12/01/2010CN101899106A Trimeric binding proteins for trimeric cytokines
12/01/2010CN101899081A Synthetic method of glycyrrhetinic acid ester derivative and deoxyglycyrrhetinic acid ester compound
12/01/2010CN101899004A Sinomenine derivatives and preparation method and medical application thereof
12/01/2010CN101898994A Method for preparing analgesic monomer from woodlouse dry powder, medical composition and purposes thereof
12/01/2010CN101898009A Medicinal bag for treating rheumatism
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897958A Superoxide dismutase eye drops and preparation method thereof
12/01/2010CN101897951A Anti-inflammatory effect of novel anti-inflammatory molecular DRP, implementation method and application
12/01/2010CN101897950A Antiviral actions, implementation method and use of novel antiviral molecule DRP
12/01/2010CN101897945A Yin-yang ascending-descending wine
12/01/2010CN101897938A Ginger tea beverage for treating cold and abating fever
12/01/2010CN101897937A External lotion for treating rheumatic arthritis
12/01/2010CN101897934A External medicament for treating soft tissue injury and osteoarthrosis and preparation method thereof
12/01/2010CN101897930A Chinese medicinal herb for treating dysmenorrhoea disease
12/01/2010CN101897928A Medicinal composition for treating ankylosing spondylitis and preparation method
12/01/2010CN101897923A Chinese medicinal powder for treating nighttime lumbago
12/01/2010CN101897918A Novel pain-reliving spraying agent and preparation technology thereof
12/01/2010CN101897913A Formula of traditional Chinese medicine for treating prosopalgia
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 1272